The Ohio State Comprehensive Cancer Center

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Myelodysplastic syndromes1 trial
• Ovarian cancer1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Geron Corporation1 trial
• Gynecologic Oncology Group1 trial

Running trials

• Active, not recruiting

  Ribociclib and Letrozole Treatment in Ovarian Cancer

  NCT03673124· Phase 2· Gynecologic Oncology Group· Source

• Active, not recruiting

  Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

  NCT02598661· Phase 2/3· Geron Corporation· Source